X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,037 | -79,732 | -24,020 | -93,867 | -64,763 |
| Depreciation Amortization | 357 | 253 | 127 | 513 | 389 |
| Accounts payable and accrued liabilities | 426 | -2,815 | -1,714 | 3,425 | -481 |
| Other Working Capital | 5,702 | 2,162 | 616 | 5,736 | 261 |
| Other Operating Activity | 6,787 | 32,195 | -1,521 | 7,091 | 6,585 |
| Operating Cash Flow | $-68,765 | $-47,937 | $-26,512 | $-77,102 | $-58,009 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | N/A | -9 | -103 | -69 |
| Net Acquisitions | N/A | -17 | N/A | N/A | N/A |
| Purchase Of Investment | -11,025 | -4,876 | N/A | N/A | N/A |
| Sale Of Investment | 1,000 | N/A | 0 | N/A | N/A |
| Investing Cash Flow | $-10,050 | $-4,893 | $-9 | $-103 | $-69 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 22,500 | -381 | -381 | N/A | N/A |
| Debt Repayment | -2,064 | -1,300 | -1,300 | -795 | -795 |
| Common Stock Issued | 68,614 | 68,895 | -443 | 122,839 | 60,693 |
| Other Financing Activity | -631 | 0 | 0 | -4,814 | -3,312 |
| Financing Cash Flow | $88,419 | $67,214 | $-2,124 | $117,230 | $56,586 |
| Exchange Rate Effect | -28 | 44 | 50 | -105 | -468 |
| Beginning Cash Position | 123,028 | 123,028 | 123,028 | 83,108 | 83,108 |
| End Cash Position | 132,604 | 137,456 | 94,433 | 123,028 | 81,148 |
| Net Cash Flow | $9,576 | $14,428 | $-28,595 | $39,920 | $-1,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,765 | -47,937 | -26,512 | -77,102 | -58,009 |
| Capital Expenditure | -25 | N/A | -9 | -103 | -69 |
| Free Cash Flow | -68,790 | -47,937 | -26,521 | -77,205 | -58,078 |